2.5.1 Detection of DRPs
The Detection of DRPs was the first outcome. The pharmacists were required to work as usual, using their professional knowledge to evaluate medication therapies. The DRPs were classified by the pharmacists who performed the medication reviews. The DRPs were recorded after evaluating the indication, dosage, adherence, adverse reactions, and therapeutic effects of each medication. It was recommended to optimize patients’ drug therapy by the pharmacists. The DRPs and recommendations were evaluated using The Pharmaceutical Care Network Europe (PCNE) Classification for Drug related problems V8.03 regarding problem, causes, planned interventions and intervention acceptance [15].
2.5.2Clinical outcomes and cost‐saving effect
The clinical outcomes and cost-saving effect were the secondary endpoints and compared on the first visit date (baseline) and the end of follow-up. The outcomes of BP was mean diastolic blood pressure (DBP)/ systolic blood pressure (SBP) of hypertensive patients on every visit. The outcomes of lipids was concluded total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG). The cost-saving effect outcome was average costs of medications per patient for every month. The drug costs were standardized over the study period.